Blickle J F, Hauptmann G, Goetz J, Tongio M M, Mayer S, Brogard J M, Dorner M
Département de Médecine Interne de la Clinique Médicale B, Centre Hospitalo-Universitaire, Strasbourg, France.
Pathol Biol (Paris). 1988 Jun;36(6):791-4.
The haplotypic frequencies of the fourth component of complement (C4) and factor B (Bf) have been determined in 44 Alsatian type 1 diabetics. An increased frequency of the rare allele Bf F1 (9.1% vs 1.5%) and of the silent alleles of C4 (C4 AQO: 21.6% vers 15.5% -C4 BQO: 29.6% vs 16.0%) was observed in diabetics in comparison to the general population of the same geographic area. A complete HLA haplotype determination has been obtained in 24 type 1 French diabetics. Three haplotypes were associated with the diabetic susceptibility: HLA-A30 CW5 B18 BfF1 C4A3BQO DR3 (18.75% vs 0.86%), HLA-A1 CW7 B8 BfS C4AQOB1 DR3 (15.58% vs 4.17%), HLA-A2 CW3 BW62 BfS C4A3B3 DR4 (6.25% vs 0.45%). The authors suggest that the silent alleles of C4 could modulate the expression of the diabetic susceptibility genes by lowering of the serum C4 hemolytic activity.
已在44例阿尔萨斯1型糖尿病患者中确定了补体第四成分(C4)和B因子(Bf)的单倍型频率。与同一地理区域的普通人群相比,糖尿病患者中罕见等位基因Bf F1(9.1%对1.5%)和C4沉默等位基因(C4 AQO:21.6%对15.5% - C4 BQO:29.6%对16.0%)的频率增加。已在24例法国1型糖尿病患者中完成了完整的HLA单倍型测定。三种单倍型与糖尿病易感性相关:HLA - A30 CW5 B18 BfF1 C4A3BQO DR3(18.75%对0.86%),HLA - A1 CW7 B8 BfS C4AQOB1 DR3(15.58%对4.17%),HLA - A2 CW3 BW62 BfS C4A3B3 DR4(6.25%对0.45%)。作者认为,C4沉默等位基因可能通过降低血清C4溶血活性来调节糖尿病易感基因的表达。